Medicofarma Biotech SA (WSE:MDB)
Poland flag Poland · Delayed Price · Currency is PLN
0.4060
-0.0040 (-0.98%)
At close: Jul 24, 2026

Medicofarma Biotech Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.281.220.754.253.343.65
Revenue Growth
-73.64%63.14%-82.34%27.45%-8.59%14.63%
Gross Profit
-2.85-2.09-2.6-1.58-0.29-0.31
Operating Income
-2.83-2.07-3.47-1.58-0.22-0.6
Net Income
-3.06-2.3-3.44-1.59-0.22-0.92
Earnings Per Share
-0.04-0.03-0.05-0.02-0.00-0.13
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
00.010.010.510.080.06
Total Debt
3.912.531.39000
Net Cash (Debt)
-3.91-2.52-1.390.510.080.06
Net Cash Growth
---556.50%20.91%-
Net Cash Per Share
-0.06-0.04-0.020.010.000.01

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-1.28-1.020.010.961.82-0.31
Capital Expenditures
00-1.11-1.21-2.30
Free Cash Flow
-1.28-1.02-1.1-0.25-0.48-0.31
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-1011.93%-170.76%-345.98%-37.09%-8.57%-8.45%
Operating Margin
-1005.43%-169.34%-462.58%-37.07%-6.54%-16.32%
Pretax Margin
-1093.60%-189.68%-486.38%-37.38%-6.45%-24.53%
Profit Margin
-1085.52%-187.82%-458.07%-37.38%-6.45%-25.09%
FCF Margin
-455.80%-83.23%-146.38%-5.83%-14.48%-8.54%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
628.6821.5398.2418.4634.635.44